Acceptability of cancer chemoprevention trials: impact of the design.
about
Reasons for and against participation in studies of medicinal therapies for women with breast cancer: a debatePreventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences.Motivators and barriers of tamoxifen use as risk-reducing medication amongst women at increased breast cancer risk: a systematic literature review.
P2860
Acceptability of cancer chemoprevention trials: impact of the design.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Acceptability of cancer chemoprevention trials: impact of the design.
@en
type
label
Acceptability of cancer chemoprevention trials: impact of the design.
@en
prefLabel
Acceptability of cancer chemoprevention trials: impact of the design.
@en
P2093
P2860
P356
P1476
Acceptability of cancer chemoprevention trials: impact of the design.
@en
P2093
Anne-Sophie Maisonneuve
Doug Horsman
Francois Eisinger
Hagay Sobol
Laetitia Huiart
Laetitia Rabayrol
Remi Didelot
P2860
P304
P356
10.7150/IJMS.5.244
P407
P577
2008-08-22T00:00:00Z